The DOI matches its Crossref record; 36 of the 36 references it cites were found in a registry or an index.
Molecular Imaging in Cancer
Abstract
Medical imaging technologies have undergone explosive growth over the past few decades and now play a central role in clinical oncology. But the truly transformative power of imaging in the clinical management of cancer patients lies ahead. Today, imaging is at a crossroads, with molecularly targeted imaging agents expected to broadly expand the capabilities of conventional anatomical imaging methods. Molecular imaging will allow clinicians to not only see where a tumor is located in the body, but also to visualize the expression and activity of specific molecules (e.g., proteases and protein kinases) and biological processes (e.g., apoptosis, angiogenesis, and metastasis) that influence tumor behavior and/or response to therapy. This information is expected to have a major impact on cancer detection, individualized treatment, and drug development, as well as our understanding of how cancer arises.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The growing impact of click chemistry on drug discovery
Kolb, H. C., & Sharpless, K. B. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02933-7 · Cited by 3,148
Molecular imaging in living subjects: seeing fundamental biological processes in a new light
Massoud, T. F., & Gambhir, S. S. (2003) · Genes & Development · doi:10.1101/gad.1047403 · Cited by 2,216
Noninvasive detection of clinically occult lymph-node metastases in prostate cancer
Harisinghani, M. G., Barentsz, J., Hahn, P. F., Deserno, W. M., Tabatabaei, S., van de Kaa, C. H., de la Rosette, J., & Weissleder, R. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022749 · Cited by 1,971
Self-citationShedding light onto live molecular targets
Weissleder, R., & Ntziachristos, V. (2003) · Nature Medicine · doi:10.1038/nm0103-123 · Cited by 1,909
Self-citationIn vivo imaging of tumors with protease-activated near-infrared fluorescent probes
Weissleder, R., Tung, C.-H., Mahmood, U., & Bogdanov, A. (1999) · Nature Biotechnology · doi:10.1038/7933 · Cited by 1,591
Self-citationLooking and listening to light: the evolution of whole-body photonic imaging
Ntziachristos, V., Ripoll, J., Wang, L. V., & Weissleder, R. (2005) · Nature Biotechnology · doi:10.1038/nbt1074 · Cited by 1,557
Self-citationEtzioni, R., Urban, N., Ramsey, S., McIntosh, M., Schwartz, S., Reid, B., Radich, J., Anderson, G., & Hartwell, L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1041 · Cited by 1,155
Cell-specific targeting of nanoparticles by multivalent attachment of small molecules
Weissleder, R., Kelly, K., Sun, E. Y., Shtatland, T., & Josephson, L. (2005) · Nature Biotechnology · doi:10.1038/nbt1159 · Cited by 904
Self-citationMolecular imaging in drug discovery and development
Rudin, M., & Weissleder, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1007 · Cited by 815
Self-citationConcurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement
Ntziachristos, V., Yodh, A. G., Schnall, M., & Chance, B. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.040570597 · Cited by 793
Positron-Emission Tomography and Assessment of Cancer Therapy
Juweid, M. E., & Cheson, B. D. (2006) · New England Journal of Medicine · doi:10.1056/nejmra050276 · Cited by 750
Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells
Anderson, D. G., Levenberg, S., & Langer, R. (2004) · Nature Biotechnology · doi:10.1038/nbt981 · Cited by 747
Scaling down imaging: molecular mapping of cancer in mice
Weissleder, R. (2002) · Nature Reviews Cancer · doi:10.1038/nrc701 · Cited by 708
Self-citationWieder, H. A., Brücher, B. L. D. M., Zimmermann, F., Becker, K., Lordick, F., Beer, A., Schwaiger, M., Fink, U., Siewert, J. R., Stein, H. J., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.122 · Cited by 454
An oncogenic KRAS2 expression signature identified by cross-species gene-expression analysis.
Sweet-Cordero, A., Mukherjee, S., Subramanian, A., You, H., Roix, J. J., Ladd-Acosta, C., Mesirov, J., Golub, T. R., & Jacks, T. (2005) · Nature Genetics · doi:10.1038/ng1490 · Cited by 414
Molecular Imaging: Looking at Problems, Seeing Solutions
Herschman, H. R. (2003) · Science · doi:10.1126/science.1090585 · Cited by 382
Molecular Imaging in the Clinical Arena
Jaffer, F. A. (2005) · JAMA · doi:10.1001/jama.293.7.855 · Cited by 369
Heinrich, S., Goerres, G. W., Schäfer, M., Sagmeister, M., Bauerfeind, P., Pestalozzi, B. C., Hany, T. F., von Schulthess, G. K., & Clavien, P.-A. (2005) · Annals of Surgery · doi:10.1097/01.sla.0000172095.97787.84 · Cited by 321
Keller, M., Montgomery, S., Ball, W., Morrison, M., Snavely, D., Liu, G., Hargreaves, R., Hietala, J., Lines, C., Beebe, K., et al. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.07.013 · Cited by 286
Avril, N., Sassen, S., Schmalfeldt, B., Naehrig, J., Rutke, S., Weber, W. A., Werner, M., Graeff, H., Schwaiger, M., & Kuhn, W. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.965 · Cited by 283
Big physics, small doses: the use of AMS and PET in human microdosing of development drugs
Lappin, G., & Garner, R. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1037 · Cited by 260
Gross, S., & Piwnica-Worms, D. (2005) · Cancer Cell · doi:10.1016/j.ccr.2004.12.011 · Cited by 229
Joyce, J. A., Laakkonen, P., Bernasconi, M., Bergers, G., Ruoslahti, E., & Hanahan, D. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00271-x · Cited by 211
Detection of dysplastic intestinal adenomas using enzyme-sensing molecular beacons in mice
Marten, K., Bremer, C., Khazaie, K., Sameni, M., Sloane, B., Tung, C., & Weissleder, R. (2002) · Gastroenterology · doi:10.1053/gast.2002.30990 · Cited by 204
Self-citationDo Oncologists Believe New Cancer Drugs Offer Good Value?
Nadler, E., Eckert, B., & Neumann, P. J. (2006) · The Oncologist · doi:10.1634/theoncologist.11-2-90 · Cited by 187
Rationale for Biomarkers and Surrogate End Points in Mechanism-Driven Oncology Drug Development
Park, J. W., Kerbel, R. S., Kelloff, G. J., Barrett, J. C., Chabner, B. A., Parkinson, D. R., Peck, J., Ruddon, R. W., Sigman, C. C., & Slamon, D. J. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0785 · Cited by 159
FDG-PET and Beyond: Molecular Breast Cancer Imaging
Quon, A., & Gambhir, S. S. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.11.024 · Cited by 159
Use of gene expression profiling to direct in vivo molecular imaging of lung cancer
Grimm, J., Kirsch, D. G., Windsor, S. D., Kim, C. F. B., Santiago, P. M., Ntziachristos, V., Jacks, T., & Weissleder, R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503920102 · Cited by 129
Self-citationNew magnetic resonance contrast agents as biochemical reporters
Meade, T. J., Taylor, A. K., & Bull, S. R. (2003) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2003.09.009 · Cited by 127
In vivo imaging of S-TRAIL-mediated tumor regression and apoptosis
Shah, K., Tung, C., Breakefield, X. O., & Weissleder, R. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.017 · Cited by 102
Self-citationWhole-animal cellular and molecular imaging to accelerate drug development
Contag, P. R. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(02)02268-7 · Cited by 94
New science-based endpoints to accelerate oncology drug development
Kelloff, G. J., & Sigman, C. C. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.006 · Cited by 89
Saleem, A., Harte, R., Matthews, J. C., Osman, S., Brady, F., Luthra, S. K., Brown, G. D., Bleehen, N. M., Connors, T., Jones, T., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1421 · Cited by 80
Güller, U., Nitzsche, E. U., Schirp, U., Viehl, C. T., Torhorst, J. K. H., Moch, H., Langer, I., Marti, W. R., Oertli, D., Harder, F. H., et al. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1013828710301 · Cited by 70
Novel Multiwavelength Microscopic Scanner for Mouse Imaging
Alencar, H., Mahmood, U., Kawano, Y., Hirata, T., & Weissleder, R. (2005) · Neoplasia · doi:10.1593/neo.05376 · Cited by 65
Self-citationWu, K., Cho, Y. S., Katz, J. P., Ponomarev, V., Chen‐Kiang, S., Danishefsky, S. J., & Moore, M. A. S. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0504512102 · Cited by 37
Cited by
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Hanahan, D., & Coussens, L. M. (2012) · Cancer Cell · doi:10.1016/j.ccr.2012.02.022 · Cited by 4,632
Effect of Surface Properties on Nanoparticle–Cell Interactions
Verma, A., & Stellacci, F. (2010) · Small · doi:10.1002/smll.200901158 · Cited by 2,619
Magnetic nanoparticles in MR imaging and drug delivery
Sun, C., Lee, J. S. H., & Zhang, M. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.03.018 · Cited by 2,594
Imaging and Photodynamic Therapy: Mechanisms, Monitoring, and Optimization
Celli, J. P., Spring, B. Q., Rizvi, I., Evans, C. L., Samkoe, K. S., Verma, S., Pogue, B. W., & Hasan, T. (2010) · Chemical Reviews · doi:10.1021/cr900300p · Cited by 2,324
Nahrendorf, M., Swirski, F. K., Aikawa, E., Stangenberg, L., Wurdinger, T., Figueiredo, J.-L., Libby, P., Weissleder, R., & Pittet, M. J. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070885 · Cited by 2,300
Self-citation
Metadata
- Authors
- Weissleder, R.
- Venue
- Science
- Published
- 2006-05-26
- Volume
- 312
- Issue
- 5777
- Pages
- 1168-1171
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2059246878
- Cited by
- 1,112
- References
- 36
- FWCI
- 41.81
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.